Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Int J Mol Sci ; 23(19)2022 Oct 10.
Artigo em Inglês | MEDLINE | ID: mdl-36233344

RESUMO

Hypertrophy and hyperplasia of white adipocytes induce obesity, leading to diseases such as type 2 diabetes and hypertension, and even cancer. Hypertrophy of white adipocytes is attributed to the excessive storage of the energy form of triglycerides in lipid droplets (LDs). LDs are fat storage organelles that maintain whole-body energy homeostasis. It is important to understand the mechanism of LD formation for the development of obesity therapy; however, the regulatory mechanisms of LD size and formation are not fully understood. In this study, we demonstrated that the PPM family phosphatase PPM1D regulates LD formation. PPM1D specific inhibitor, SL-176 significantly decreased LD formation via two different pathways: dependent of and independent of adipocyte-differentiation processes. In the mature white adipocytes after differentiation, LD formation was found to be controlled by PPM1D via dephosphorylation of Ser511 of perilipin 1. We found that inhibition of PPM1D in mature white adipocytes significantly reduced the size of the LDs via dephosphorylation of Ser511 of perilipin 1 but did not change the lipolysis sensitivity and the total amount of lipid in cells. Collectively, the results of this study provide evidence that PPM1D plays an important role in LD formation in mature adipocytes.


Assuntos
Diabetes Mellitus Tipo 2 , Gotículas Lipídicas , Proteína Fosfatase 2C , Adipócitos/metabolismo , Diabetes Mellitus Tipo 2/metabolismo , Humanos , Hipertrofia/metabolismo , Gotículas Lipídicas/metabolismo , Metabolismo dos Lipídeos , Lipólise , Obesidade/metabolismo , Perilipina-1/metabolismo , Perilipina-2/metabolismo , Monoéster Fosfórico Hidrolases/metabolismo , Proteína Fosfatase 2C/metabolismo , Triglicerídeos/metabolismo
2.
PLoS One ; 14(2): e0212682, 2019.
Artigo em Inglês | MEDLINE | ID: mdl-30811466

RESUMO

Obesity is a worldwide public health problem, which is associated with various severe diseases including diabetes, hypertension, atherosclerosis, and cancer. Recent studies have revealed that combination treatment of several different compounds using low doses is effective to reduce side effects. Thus, there is a need to develop an efficient inhibitor for reducing lipid droplets with a divergent target/pathway. Ser/Thr protein phosphatase PPM1D is involved in cellular metabolic processes and is a promising target for anti-obesity treatment. We have previously developed a potent and specific PPM1D inhibitor, SL-176. In this study, we demonstrated that significant reduction of lipid droplet formation in adipocytes by the PPM1D specific inhibitor, SL-176. Using Oil-red O staining and fluorescent imaging of lipid droplet, we found that treatment of SL-176 significantly suppressed lipid droplet formation of 3T3-L1 cells both in amount and in size. SL-176 also repressed mRNA and protein expression of PPARγ and C/EBPα, adipogenic markers, at nontoxic conditions. Thus, SL-176 is a unique and potent inhibitor of lipid droplet formation that acts via PPM1D, a novel target toward inhibiting adipocyte differentiation.


Assuntos
Adipócitos/efeitos dos fármacos , Fármacos Antiobesidade/farmacologia , Gotículas Lipídicas/efeitos dos fármacos , Naftalenos/farmacologia , Compostos de Organossilício/farmacologia , Proteína Fosfatase 2C/antagonistas & inibidores , Células 3T3-L1 , Adipócitos/citologia , Adipócitos/fisiologia , Adipogenia/efeitos dos fármacos , Animais , Fármacos Antiobesidade/uso terapêutico , Diferenciação Celular/efeitos dos fármacos , Avaliação Pré-Clínica de Medicamentos , Camundongos , Naftalenos/uso terapêutico , Obesidade/tratamento farmacológico , Compostos de Organossilício/uso terapêutico , Proteína Fosfatase 2C/metabolismo
3.
PLoS One ; 11(8): e0160625, 2016.
Artigo em Inglês | MEDLINE | ID: mdl-27490470

RESUMO

Nuclear and cytoplasmic morphological changes provide important information about cell differentiation processes, cell functions, and signal responses. There is a strong desire to develop a rapid and simple method for visualizing cytoplasmic and nuclear morphology. Here, we developed a novel and rapid method for probing cellular morphological changes of live cell differentiation process by a fluorescent probe, TAP-4PH, a 1,3a,6a-triazapentalene derivative. TAP-4PH showed high fluorescence in cytoplasmic area, and visualized cytoplasmic and nuclear morphological changes of live cells during differentiation. We demonstrated that TAP-4PH visualized dendritic axon and spine formation in neuronal differentiation, and nuclear structural changes during neutrophilic differentiation. We also showed that the utility of TAP-4PH for visualization of cytoplasmic and nuclear morphologies of various type of live cells. Our visualizing method has no toxicity and no influence on the cellular differentiation and function. The cell morphology can be rapidly observed after addition of TAP-4PH and can continue to be observed in the presence of TAP-4PH in cell culture medium. Moreover, TAP-4PH can be easily removed after observation by washing for subsequent biological assay. Taken together, these results demonstrate that our visualization method is a powerful tool to probe differentiation processes before subsequent biological assay in live cells.


Assuntos
Compostos Bicíclicos Heterocíclicos com Pontes/química , Diferenciação Celular , Núcleo Celular/metabolismo , Citoplasma/metabolismo , Corantes Fluorescentes/química , Células 3T3-L1 , Células A549 , Animais , Ciclo Celular , Linhagem Celular Tumoral , Núcleo Celular/química , Citoplasma/química , Células HEK293 , Humanos , Camundongos , Microscopia de Fluorescência , Células PC12 , Fagocitose , Ratos , Espectrometria de Fluorescência
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...